These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 6871874

  • 1. Progesterone-specific stimulation of triglyceride biosynthesis in a breast cancer cell line (T-47D).
    Judge SM, Chatterton RT.
    Cancer Res; 1983 Sep; 43(9):4407-12. PubMed ID: 6871874
    [Abstract] [Full Text] [Related]

  • 2. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
    Shiu RP, Paterson JA.
    Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
    [Abstract] [Full Text] [Related]

  • 3. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
    Ng KW, Livesey SA, Larkins RG, Martin TJ.
    Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
    Chetrite GS, Paris J, Shields-Botella J, Philippe JC, Pasqualini JR.
    Anticancer Res; 2003 Feb; 23(6C):4651-5. PubMed ID: 14981909
    [Abstract] [Full Text] [Related]

  • 6. Milk fat conjugated linoleic acid (CLA) inhibits growth of human mammary MCF-7 cancer cells.
    O'Shea M, Devery R, Lawless F, Murphy J, Stanton C.
    Anticancer Res; 2000 Feb; 20(5B):3591-601. PubMed ID: 11131667
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
    Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, Stanczyk FZ, Stolz A.
    Cancer Res; 2004 Oct 15; 64(20):7610-7. PubMed ID: 15492289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM, Murthy L, Stancel GM.
    Cancer Res; 1998 Feb 01; 58(3):392-5. PubMed ID: 9458078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, López-Otín C.
    Cancer Res; 1997 Sep 15; 57(18):4091-7. PubMed ID: 9307298
    [Abstract] [Full Text] [Related]

  • 18. Hormonal regulation of de novo pyrimidine synthesis and utilization in human breast cancer cells in tissue culture.
    Aitken SC, Lippman ME.
    Cancer Res; 1983 Oct 15; 43(10):4681-90. PubMed ID: 6883327
    [Abstract] [Full Text] [Related]

  • 19. Altered response to thyroid hormones by breast and ovarian cancer cells.
    Martinez MB, Ruan M, Fitzpatrick LA.
    Anticancer Res; 2000 Oct 15; 20(6B):4141-6. PubMed ID: 11205239
    [Abstract] [Full Text] [Related]

  • 20. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S, Wong BC, Archer DF.
    Fertil Steril; 2005 Aug 15; 84(2):485-91. PubMed ID: 16084894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.